top of page

Doug Niven PhD

Strategy Leader in Market Access, Go-to-Market & Portfolio Optimisation

I'm passionate about where science meets economic value, helping innovations prove their worth in the real world.

Doug Niven Strategic Leader in Market Access Portfolio Optimisation and Go-to-Market Strategy

Doug Niven has 20+ years of experience in the research, health and life science sectors.

​

  • Doug has worked extensively with both big pharma and biotechs across the product lifecycle, as well as med tech companies and financial investors

​

  • Doug  has supported the development and commercialisation of over 20 different drugs, covering a broad range of therapeutic areas and modalities at global, regional and country levels

​

Experience and highlights

  • Asset Lead: enabling biotechs to achieve critical development and commercial milestones

  • Director of Strategic Consulting: supporting large and small pharma clients to optimise commercial strategy and execution, due diligence exercises and lifecycle management excellence​

  • Broad disease area experience: inflammation and immunology, neurology, rare diseases, oncology, behavioral/mental health, ophthalmology, respiratory, cardiovascular​

  • Varied treatment modality experience: small molecules, biologics, cell therapies, digital therapeutics, and medical devices

​​

Leadership and building partnerships:

  • Business development and strategic alliances with large pharma and biotechs

  • Direct and matrix leadership across different functions

  • Professional consultancy and CRO-CCO experience, including strategic market analysis and market access

​

bottom of page